Cas:54005-84-4 7-Bromoheptanal manufacturer & supplier

We serve Chemical Name:7-Bromoheptanal CAS:54005-84-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

7-Bromoheptanal

Chemical Name:7-Bromoheptanal
CAS.NO:54005-84-4
Synonyms:7-Bromheptanal;7-bromo-1-heptanal;7-bromo-heptanal;7-Bromoheptanal;Heptanal, 7-bromo-;7-bromoheptanaldehyde;Heptanal,7-bromo
Molecular Formula:C7H13BrO
Molecular Weight:193.081
HS Code:2913000090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:222.3±23.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.461
PSA:17.07000
Exact Mass:192.014969
LogP:2.36

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 7-Bromheptanal chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Heptanal,7-bromo physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Heptanal, 7-bromo- Use and application,7-bromo-heptanal technical grade,usp/ep/jp grade.


Related News: At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. 7-Bromoheptanal manufacturer Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business. 7-Bromoheptanal supplier Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business. 7-Bromoheptanal vendor First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. 7-Bromoheptanal factory At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.